Atlas Trials

A Study of the Dose Proportionality of Extended Release Paliperidone

Clinical trial NCT00791167 · COMPLETED

Trial details

NCT number
NCT00791167
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2006-06-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.